Clinical Trials Logo

Pelvic Floor Disorders clinical trials

View clinical trials related to Pelvic Floor Disorders.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT03934996 Withdrawn - Clinical trials for Stress Urinary Incontinence

Quality and Behavior of Pelvic Floor in Runner Women

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

The main objective is to analyze the relationship between the PF muscles and the other variables along the different tasks of daily life and during the race.

NCT ID: NCT03028753 Withdrawn - Clinical trials for Pelvic Floor Disorders

Accuracy of Bladder Scanners in Post-operative Voiding Trials

Start date: August 2016
Phase: N/A
Study type: Interventional

The investigators are trying to determine if using a bladder scanner (type of ultrasound) to check how much urine is left in the bladder is the same as checking that volume with a catheter (tube that goes into your bladder to drain urine). After urogynecologic surgery, the investigators perform a voiding trial. Water is put into the participant's bladder through the catheter (tube draining your bladder). The catheter is then removed and the participant is asked to empty their bladder. After that, the investigators will use the bladder scanner (ultrasound) to see how much urine is left in the participant's bladder. After the ultrasound, the investigators will pass a very small catheter (tube) into the bladder to take out the remaining urine. The investigators will then compare the amount obtained from the catheter to the ultrasound amount. This will also help the investigators to figure out if they need to check how much urine is left in a patient's bladder after the voiding trial.

NCT ID: NCT02860897 Withdrawn - Surgery Clinical Trials

Patient Adherence to Premarin Versus Vagifem Therapy After Female Pelvic Reconstructive Surgery

Start date: July 2016
Phase: Phase 4
Study type: Interventional

PURPOSE: To evaluate patient adherence to cream versus tablet based local estrogen therapy by randomizing treatment modalities to determine differences in adherence to either form. HYPOTHESIS: There is no difference in adherence to cream versus tablet based local estrogen therapy when prescribed as a 6 week course of postoperative therapy after female pelvic reconstructive surgery.